X

Trial Profile

A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis: Single Centre, Phase 2 Trial

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 22 Jan 2020

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Lamotrigine (Primary)
Indications Multiple sclerosis
Focus Therapeutic Use

Most Recent Events

13 Apr 2010 Results were presented at the 62nd Annual Meeting of the American Academy of Neurology.
09 Sep 2009 Results have been presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis.
12 Feb 2009 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com